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Abstract
Arsenic, a known human carcinogen, is widely distributed around the world and found in particularly high concentrations in
certain regions including Southwestern US, Eastern Europe, India, China, Taiwan and Mexico. Chronic arsenic poisoning
affects millions of people worldwide and is associated with increased risk of many diseases including arthrosclerosis,
diabetes and cancer. In this study, we explored genome level global responses to high and low levels of arsenic exposure in
Caenorhabditis elegans using Affymetrix expression microarrays. This experimental design allows us to do microarray
analysis of dose-response relationships of global gene expression patterns. High dose (0.03%) exposure caused stronger
global gene expression changes in comparison with low dose (0.003%) exposure, suggesting a positive dose-response
correlation. Biological processes such as oxidative stress, and iron metabolism, which were previously reported to be
involved in arsenic toxicity studies using cultured cells, experimental animals, and humans, were found to be affected in C.
elegans. We performed genome-wide gene expression comparisons between our microarray data and publicly available C.
elegans microarray datasets of cadmium, and sediment exposure samples of German rivers Rhine and Elbe. Bioinformatics
analysis of arsenic-responsive regulatory networks were done using FastMEDUSA program. FastMEDUSA analysis identified
cancer-related genes, particularly genes associated with leukemia, such as dnj-11, which encodes a protein orthologous to
the mammalian ZRF1/MIDA1/MPP11/DNAJC2 family of ribosome-associated molecular chaperones. We analyzed the
protective functions of several of the identified genes using RNAi. Our study indicates that C. elegans could be a substitute
model to study the mechanism of metal toxicity using high-throughput expression data and bioinformatics tools such as
FastMEDUSA.
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Introduction
Arsenic is a metalloid, which is distributed throughout the Earth
crust in diverse complex forms with pyrites. Depending on the
physicochemical conditions of the environment, arsenic can
readily be dissociated from the complex, enter into ground water
[1] and be taken up by microorganisms resulting in high levels of
bio-availability [1,2]. In Asia, including India, Bangladesh,
Vietnam, Thailand and China millions of people are exposed to
arsenic. Two different oxidative states of arsenic, (III) and (V), are
available in organic and inorganic forms that correlate with their
cytotoxic potentials. Between these two states, compounds with
(+3) oxidation state are more toxic to target cells and tissues due to
several mechanisms including high affinity for protein thiols or
vicinal sulfhydryl groups [3–8].
Chronic and/or acute high dose arsenic exposure can cause
wide range of health problems including cancer, severe gastroin-
testinal toxicity, diabetes, cardiovascular disease and even death
[5,8,9]. Arsenic is considered as a group1 carcinogen, a categorical
classification of an agent/mixture, which is definitely carcinogenic
to humans [10]. Since carcinogenic metals, including arsenic, tend
to be weak mutagens, and they do not directly interact with DNA,
several recent studies have suggested that epigenetic regulation
may play a role in metal-induced carcinogenesis [11].
Although the metabolism of inorganic arsenic is quite well
known, the precise mechanism of arsenic toxicity is not clearly
understood. In mammals, a methylation pathway has been
proposed for the metabolic processing of inorganic arsenicals. In
this pathway, arsenite (iAsIII) is sequentially converted to
monomethylarsonic acid (MMAv) and dimethylarsinic acid
(DMAv) in both humans and laboratory animals including mice
and rats. The intermediate arsenicals, MMAIII and DMAIII, also
produced in this pathway, are highly toxic and suspected to be
responsible for arsenic toxicity [12]. While some steps in this
pathway are strictly chemical reactions, others are enzymatically
catalyzed. However, work to date has identified one methyltrans-
ferase that is clearly a participant in this pathway. Arsenic (+3
oxidation state) methyltransferase (AS3MT)1 catalyzes conversion
of iAs to methylated products. AS3MT homologs have not been
identified in C. elegans genome [13]. Other aspects of arsenic
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metabolism in C. elegans remain to be seen. Arsenic causes
oxidative stress, apoptosis and mutagenesis [14–16]. Oxidative
stress through generation of reactive oxygen species due to arsenic
exposure [17–20] have been reported in tumor cell lines [21] as
well as in normal human cells [22,23].
While arsenic is mostly documented as an inducing factor in
cancers or several other diseases, there is extensive evidence that
one form of arsenic, As2O3, has a potential antitumor effect in vitro
and in vivo [24–26]. United States Food and Drug Administration
(US-FDA) approved As2O3 for the treatment of Acute Promyelo-
cytic Leukemia (APL). It’s well established that As2O3 can
completely cure ,80–90% of newly diagnosed APL patient [24–
26].
C. elegans, a model organism that is less complex than the
mammalian system while still sharing high genomic homology,
provides an excellent model to elucidate the mechanisms of heavy
metal toxicity [27]. This soil nematode has been used in toxicology
studies, revealing molecular mechanisms of heavy metal toxicity
[28], [29], [30]. Therefore, the C. elegans model system is valuable
for the investigation of metal toxicity and may be particularly
useful for examining gene-environment interactions. Several
toxicity endpoints are well documented in the nematode, including
growth rate, lifespan, reproduction, and feeding [31,32]. Acute
toxicity can also be assessed in the nematode using altered gene
expression levels, as well as behavioral endpoints, such as
locomotion, and head thrashing [33–37]. Several cellular stress
response systems such as the glutathione (GSH), metallothioneins
(MTs), heat shock proteins (HSPs), as well as a variety of pumps
and transporters are found to work to detoxify and excrete metals
in C. elegans [27]. Previously, whole genome C. elegans DNA
microarray and RNAi analysis were used to explore global
changes in this nematode to understand mechanisms involved in
resistance to cadmium toxicity [38].
In this study we used C. elegans whole genome expression
microarrays to examine global changes in the nematode
transcription profile upon arsenic exposure. Bioinformatics anal-
ysis of regulatory networks was done using FastMEDUSA. We
analyzed the protective functions of several of the identified genes
using RNAi. Molecular players previously associated with arsenic
exposure in higher organisms were identified at a global level,
confirming the effectiveness of the study. Moreover, we identified
evolutionary conserved genes which were not previously associated
with arsenic exposure, but associated with carcinogenesis.
Materials and Methods
Bacterial strains, media and culture conditions
Eight RNAi bacterial strains were used in this study including:
sdz-8, ftn-1, hsp-70, numr-1, aip-1, gst-37, gcs-1, and L4440 (empty
vector control) [39].
C. elegans strains and maintenance
Strains N2, NL2099 rrf-3(pk1426), VC1642 dnj-11(gk1025), and
VC392 dac-1(gk211) were acquired from Caenorhabditis Genetics
Center (CGC). Strains were maintained at 22uC. The wild type
Bristol strain N2, was cultured in C. elegans habitation media
(CeHM) in tissue culture flasks on a platform shaker [40].
Nematodes were bleached (0.5M NaOH, 1% Hypochlorite) to
collect eggs which were incubated in M9 media for 24 hours to
bring them to synchronized L1 stage and then transferred to C.
elegans habitation media (CeHM).
Arsenic treatment for microarray experiments
Synchronized L1 stage animals were collected by spinning at
800 rpm for five minutes and transferred to Sodium arsenite
containing (0.03% and 0.003% w/v) CeHM media and incubated
at 22uC for 6 hours.
RNA Isolation
After arsenic treatment animals were collected and washed in
M9 buffer, RNA was extracted using TRIzol reagent (Invitrogen).
Residual genomic DNA was removed by DNase treatment
(Ambion, Austin, TX). Three independent RNA isolations were
performed with each condition for microarray analysis.
Microarray Analysis
For each experimental condition, RNA was isolated from three
biological replicate samples. cRNA was synthesized from 10 mg of
total RNA, and samples were hybridized to the C. elegans
GeneChip (Affymetrix, Santa Clara, CA) by the US Food and
Drug Administration/CFSAN/DMB Microarray Facility follow-
ing the manufacturers instruction. The chip represents 22,500
transcripts of the expressed C. elegans genome based on the
December 2005 genome sequence. The data were processed using
Partek Genomics Suite, version 6.5 (Copyright  2010 Partek
Inc., St. Louis, MO, USA). The robust multichip averaging
(RMA) algorithm was used to normalize and summarize the probe
data into probeset expression values. The RMA algorithm
performs background correction, normalization, and summariza-
tion using PM-only probes (Figure S1). A gene usually maps to
several probesets. To convert probeset-level expression data to
gene-level, we picked the highest-intensity probeset of each gene.
We used ANOVA to compute differentially expressed genes
between experimental treatment groups and control using the log
transformed normalized intensity values generated from applica-
tion of the RMA algorithm. We used the FDR for multiple
comparison correction. Genes were considered differentially
expressed if they had a p-value#0.05 after correction. The
microarray data have been deposited in the GEO repository.
Accession number is GSE39012.
Functional Enrichment Analysis
Genes showing a significant change in expression by microarray
analysis (FDR,0.05) were analyzed using ‘stats’ R package of R
software (R Development Core Team [2012]: A language and
environment for statistical computing. R foundation for Statistical
Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://
www.R-project.org). Genes were compared against a 21,249 C.
elegans gene database to identify over-represented Gene Ontology
terms. Statistical analysis was performed using chi-square test and
the Yates’ continuity correction. Significant functional terms were
defined as p,0.05.
qRT-PCR
cDNA was synthesized from 5 mg of total RNA using random
hexamers and SuperScript II reverse transcriptase (Invitrogen).
Real time PCR was performed using SYBR Advantage quanti-
tative PCR premix (Clontech) and gene-specific oligonucleotide
primers on the LightCycler (Roche). Primers for qRT-PCR are
listed on Table S1. Relative fold-changes for transcripts were
calculated using the comparative CT (2
2DDCT) method [41]. Cycle
thresholds of amplification were determined by Light Cycler
software (Roche). All samples were run in triplicates and
normalized to GAPDH.
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RNA Interference
E. coli DH5a bacterial strains expressing double-stranded C.
elegans RNA [42] were grown in LB broth containing ampicillin
(100 mg/ml) at 37uC and plated onto NGM containing 100 mg/ml
ampicillin and 3 mM isopropyl 1-thio-b-D-galactopyranoside
(IPTG). RNAi-expressing bacteria were allowed to grow overnight
at 37uC. Synchronized L1 stage NL2099 (rrf-3) strains were used
for RNAi experiments for the functional validation of the
differentially expressed genes identified through microarray.
NL2099 (rrf-3) worms were exposed to fresh RNAi expressing
bacterial lawn on NGM agar plates for 48 hours, then washed
with M9 and plated on sodium arsenite containing NGM plates
with E.coli OP50 bacterial lawn, and incubated at 22uC (See ‘C.
elegans survival assays for arsenic exposure following RNAi’ section
below). L4440 RNAi which contains the RNAi plasmid only was
included as a control in all experiments.
C. elegans survival assays for arsenic exposure following
RNAi
Sodium arsenite containing (0.03%) nematode growth media
(NGM), in 6-cm Petri plates, were prepared for survival assays.
The plates contained a lawn of OP50 bacteria as a food source.
Plates were incubated overnight at room temperature before
animals were added. Worms (L1 stage), treated with RNAi
bacteria for 48 hours, were transferred to sodium arsenite
containing NGM plates with OP50 bacterial lawns and incubated
at 22uC. Around 20–30 L4 stage worms were added to each plate.
Total 75 to 100 animals were scored for each condition every 24 h
for survival and transferred to fresh bacterial lawns every day to
avoid overgrowth by progeny. Assay was continued up to ten days.
Animal survival was plotted using Kaplan-Meier survival curves
and analyzed by log rank test using Graph Pad Prism (Graph Pad
Software, Inc., La Jolla, CA). Survival curves resulting in p values
of ,0.05 relative to control were considered significantly different.
FastMEDUSA analysis
We used FastMEDUSA [43] to elucidate transcription factors
(TFs) that putatively regulate the genome-level responses to high
and low levels of arsenic exposure in C. elegans. FastMEDUSA
applies a machine learning algorithm called boosting to train a
predictive model from expression and promoter sequences of
genes in a number of experimental conditions. FastMEDUSA uses
a list of candidate TFs, the promoter sequences of all the genes and
a matrix of discrete expression data as input. To discretize gene
expression data, we computed fold change of expression signal of a
gene in a sample to the gene’s median expression across reference
samples. A gene in a sample was called upregulated if the fold
change $1.5 and downregulated if the fold change is #21.5.
Genes having inconsistent expression calls across technical
replicates were filtered out. We obtained the list of candidate
TFs in C. elegans from EDGEdb [44], and obtained 1,000 bp
promoter sequence of genes from BioMart [45].
FastMEDUSA potentially builds a different model at each run
as it contains some stochastic steps. Thus, we ran FastMEDUSA
five times using a different random seed value at each run on the
Biowulf cluster at the National Institutes of Health. For each
FastMEDUSA run, we computed significance score of TFs as
following. First, we computed prediction score for the upregulated
genes in the experimental condition based on the original
FastMEDUSA model. Then, we remove the TF from the
FastMEDUSA model and recomputed the prediction score for
the same gene set. The difference between the prediction scores
give the significance score of the TF (details in [46]). We selected
top 20 TFs with highest significance score. Then we selected top
ten consensus significant TFs that were selected as significant in at
least four out of five runs. To find significant TF-gene associations,
we computed the significance score for each TF-gene pair. We
selected TF-gene associations that had a significance score$1 for
at least four out of five runs and generated a network of these
associations by using Cytoscape [47].
Results and Discussion
Arsenic exposure induced genome-wide gene expression
changes in C. elegans
Arsenic induced global gene expression has been poorly
explored. To study the global gene expression pattern after acute
arsenic exposure, we performed a microarray study where wild
type L4 stage C. elegans (N2) was exposed to sodium arsenite in two
different concentrations (0.03% and 0.003% w/v) in CeHM
media for 6 hours. Differentially expressed genes were identified
(considering fold change (+/2) 1.2 fold, FDR=0.05 and P,0.05).
C. elegans gave a strong global gene expression response to sodium
arsenite where about one fifth of the genome (4731 genes) was
differentially expressed upon high dose (0.03% w/v) exposure.
Low dose (0.003% w/v) sodium arsenite led to differential
expression in 218 genes, 179 of those were common between
the two exposures (Fig. 1). Microarray data were confirmed using
qRT-PCR to measure the expression levels of a set of selected
genes (Fig. S2).
Comparison of gene expression changes between high
and low levels of sodium arsenite exposure
We exposed worms to two different concentration of sodium
arsenite to evaluate the genomic responses to different levels of
arsenic exposure. This experimental design allows us to do
microarray analysis of dose-response relationships of global gene
expression patterns. High dose (0.03%) exposure caused stronger
global gene expression changes in comparison with low dose
(0.003%) exposure (Fig. 1, Table S2). Two hundred and four genes
were up regulated four fold and higher upon high dose exposure,
and forty nine genes were up regulated four fold and up upon low
dose exposure. Forty six of these were common between these lists
(Table 1). Forty three of forty six commonly upregulated genes
show dose-response relationship where high levels of sodium
arsenite led to higher gene expression levels in C. elegans (Table 1).
At eight hours exposure we did not observe anatomical level
changes in tissue structure, and lethality (data not shown).
Protective function of the subset of the genes up-
regulated against arsenic treatment was evaluated using
RNAi
We wanted to test whether knocking down the upregulated
genes will affect the sodium arsenite induced lethality in C. elegans.
Four out of seven genes tested, caused statistically significant
increase in lethality upon sodium arsenite exposure when knocked-
out via RNAi, suggesting that these genes may have stress response
function against arsenic (Fig. 2). Among these genes, aip-1 encodes
an AN-1-like zinc finger-containing protein homologous to
arsenite-inducible RNA-associated protein (AIRAP), which is
conserved among C. elegans, Drosophila, and mammals. AIP-1 is
a predicted RNA binding protein that may function in ubiquitin-
mediated proteolysis following arsenite treatment. AIP-1 is
expressed at high levels in hypodermal and intestinal cells of C.
elegans following arsenic exposure, and previously shown to protect
C. elegans and mammalian cells from arsenite toxicity [48]. Our aip-
Genomic Analysis of Arsenic Response in C. elegans
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1 RNAi results agree with the previously published data (Fig. 2A).
gcs-1 encodes the C. elegans ortholog of gamma-glutamylecysteine
synthetase heavy chain (GCS(h)), which is predicted to function as
a phase II detoxification enzyme that catalyzes the rate-limiting
first step in glutathione biosynthesis, in a conserved oxidative stress
response pathway [49]. Inoue et al [50] showed that the
Caenorhabditis elegans PMK-1 p38 MAPK pathway regulates the
oxidative stress response via the CNC transcription factor SKN-1,
leading to phosphorylated SKN-1 accumulation in intestine
nuclei, where SKN-1 activates transcription of gcs-1. SKN-1 also
regulates expression of AIP-1 [51]. We found that most of the C.
elegans Glutathion S-transferases (GSTs), which are important
detoxifying enzymes, responded to arsenic exposure (Table 2).
Among these genes, gst-37, previously defined as a acrylamide
responsive gene in C. elegans using expression microarrays [52]. gst-
37 RNAi experiments resulted in increased lethality in arsenic
exposure conditions (Figure 2B). In our microarray data several hsp
(heat-shock protein) genes found to be responsive to sodium
arsenite (Table 2). HSP-70 is a member of the hsp70 family of
molecular chaperones, involving in general stress response,
including response to heat and cadmium exposure, in C. elegans
[30,53]. We found that hsp-70 RNAi leads to increased lethality in
arsenic exposure conditions (Figure 2D). Arsenic toxicity leads to
induced HSP70 in other systems including Xenopus laevis embryos
[54], and broiler chickens [55]. Oxidative stress, the central
component of heat shock response, is also induced by arsenic [56].
Oxidative stress- response genes are induced due to
sodium arsenite exposure
Our microarray data revealed that genomic response of C.
elegans to sodium arsenite exhibits characteristics of global
oxidative stress response (Fig. 3). Oxidative stress from arsenic
exposure might result from production of Reactive Oxygen
Species (ROS), such as superoxide, hydrogen peroxide, or
hydroxyl radical by arsenicals, or from release of iron from
ferritin or through induction of heme oxygenase. Increased
biosynthesis of defensive enzymes responsive to oxidative stress
has been described in both prokaryotes and eukaryotes. We
compared our arsenic-response microarray data with previously
published C. elegans global stress-response results. C. elegans’
response to both, paraquat- induced stress [57] (Fig. 3A, Table
S4), and hyperbaric oxygen-induced stress [58] (Fig. 3B, Table S5)
showed significant overlap with our arsenic-response microarray
data. We performed Gene Ontology (GO) Term enrichment
analysis on our high dose arsenic response data (Figure 1C) along
with paraquat and hyperbaric oxygen stress data (Figure 3C and
3D). General stress related GO categories, such as ‘unfolded
protein binding’, ‘protein folding’, ‘protein transport’, and
proteolysis were found to be enriched under high dose arsenic
exposure conditions (Fig. 1C). Some of the protein folding, and
transport related GO term enrichments were also present in
paraquat stress data but not in hyperbaric oxygen stress data
(Fig. 3C, D), suggesting that arsenic and paraquat result in similar
functional responses in C. elegans. Interestingly, expression of zinc
ion binding gene classes was depleted in all of these stresses
Figure 1. Genome-wide expression profile comparisons of C. elegans genes regulated by arsenic and cadmium. (A) A Venn diagram
illustrating number of genes expressed at low and high dose arsenic exposure, 4-hour cadmium exposure, and overlap among these data. (B) A Venn
diagram illustrating number of genes expressed at low and high dose arsenic exposure, 24-hour cadmium exposure, and overlap among these data.
(C) Enrichment of gene ontology categories for genes differentially expressed at high dose arsenic exposure.
doi:10.1371/journal.pone.0066431.g001
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(Fig. 1C, 3C–D). The essential trace element zinc is broadly
required in cellular functions, and disturbances in zinc homeostasis
cause a range of health problems that include growth retardation,
immunodeficiency, neuronal and sensory dysfunctions [59].
Glutathion S-transferases (GSTs) are essential detoxifying
enzymes that constitute up to 10% of cytosolic protein in some
mammalian organs, and catalyze the conjugation of reduced
glutathione on a wide variety of substrates [60,61]. This activity
detoxifies endogenous compounds such as peroxidised lipids [62].
GSTs may also bind toxins and function as transport proteins [63].
C. elegans genome possesses a large number of GST genes. We
found that sixty seven percent of (thirty three of forty nine) the C.
elegans gst genes are differentially expressed upon arsenic exposure
(Table 2). Other genes encoding antioxidant enzymes such as
catalase, superoxide dismutase, and glutathione peroxidase are
differentially expressed in arsenic-exposed C. elegans (Table 2).
Lynn et. al. [64] reported that arsenite activates NADH oxidase to
produce superoxide, which then causes oxidative DNA damage.
We found that putative NADH oxidase encoding gene F56D5.3 is
upregulated 43 fold in arsenic exposed C. elegans (Table 2). Recent
studies revealed an association between sonic hedgehog signaling
and oxidative stress in several different tissues including rat brain
and mouse bone marrow [65,66]. Twenty of the fifty eight
hedgehog related genes of C. elegans, found to be differentially
expressed upon arsenic exposure (Table 2). Functions of sonic
hedgehog signaling genes in arsenic toxcicity and protection
remain to be seen.
Arsenic-induced perturbations in iron metabolism may
lead to oxidative stress
Almost all cells utilize iron as a cofactor for essential
biochemical activities, such as oxygen transport, energy metabo-
lism and DNA synthesis. However, iron catalyses the propagation
of ROS and generation of highly reactive radicals through fenton
chemistry, hence, free iron is potentially toxic to cells [67,68].
Much of the excess intracellular iron is stored in the cytosol, bound
to ferritin. Very little is known about the interaction of the species
of arsenic with free iron at the cellular level. Release of iron from
ferritin is an under investigated possible mechanism of arsenic
induced oxidative stress. It has been shown that arsenic species can
cause release of iron from horse spleen ferritin in vitro [69]. Iron
administration into HeLa cells leads to increased ferritin mRNA
levels [70]. We found that ferritin encoding genes of C. elegans, ftn-
1, and ftn-2 are upregulated upon sodium arsenite exposure
(table 2). There is strong experimental support suggesting a
protective role for ferritin against oxidative stress. Both transcrip-
tional and posttranscriptional mechanisms have been implicated in
ferritin induction by oxidants, such as ROS, and nitric oxide
[71,72]. C. elegans homologs of iron transporter ferroportin, fpn-1.1
and fpn-1.2 are also differentially expressed against sodium arsenite
(Table 2). Sideroflexins are recently discovered mitochondrial
multiple transmembrane proteins with unknown function, which
are associated with iron accumulation in mitochondria [73]. We
found that C. elegans sideroflexin genes sfxn-2 and sfxn-5 are
downregulated upon arsenic exposure. Altogether, our data
suggest that arsenic may induce perturbations in proteins involved
in iron metabolism.
Genomic response to arsenic versus cadmium in C.
elegans
Heavy metals such as copper, zinc, cadmium, and metalloids
such as arsenic, are major environmental toxicants that are
associated with a variety of human diseases. In spite of extensive
research on the pathogenesis of human diseases which are linked
Figure 2. Arsenic induced genes mediate stress response. (A) aip-1, p,0.0001, (B) gst-37, p = 0.0085, (C) gcs-1, p,0.0001 and (D) hsp-70,
p = 0.04, RNAi results in lethality in C. elegans exposed to sodium arsenite.
doi:10.1371/journal.pone.0066431.g002
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Table 1. List of genes up-regulated (.4 times) in both high and low dose arsenic exposure.
Gene name Brief description
Fold-Change (03%
vs No Treatment) p-value
Fold-Change (003%
vs No treatment) p-value
numr-1 unknown 140.416 4.44E-09 25.1465 5.73E-08
W06H8.2 unknown 91.5165 2.23E-09 25.2296 1.67E-08
gst-30 glutathione S-transferase 64.4519 2.75E-10 12.8297 5.18E-09
T19D12.3 unknown 63.3912 2.67E-09 16.5752 2.76E-08
ftn-1 ferritin heavy chain 55.3853 2.60E-08 5.7706 3.57E-06
hsp-70 heat shock protein 70 53.7595 8.41E-09 14.8787 8.61E-08
F55G11.2 unknown 46.5611 1.05E-08 23.5514 3.39E-08
gst-38 glutathione S-transferase 44.4153 2.61E-10 25.1488 6.92E-10
F56D5.3 NADH oxidase 42.8716 4.55E-07 9.13127 1.04E-05
clec-3 unknown 42.2267 1.34E-07 10.7623 1.986E-06
hsp-16.41 heat shock protein 37.3042 5.15E-09 21.7315 1.36E-08
gst-12 glutathione S-transferase 32.4796 2.51E-08 13.1085 1.52E-07
hsp-16.2 heat shock protein 31.7514 6.75E-08 15.6115 2.66E-07
gst-25 glutathione S-transferase 29.8987 2.85E-09 6.60598 9.57E-08
dod-17 unknown 27.2977 1.12E-08 9.87008 1.01E-07
Y38E10A.13 unknown 26.7901 2.41E-06 4.21829 0.0002776
clec-163 C-type lectin 26.6706 3.41E-09 6.12515 1.19E-07
aip-1 AN-1-like zinc finger-containing
protein
20.8251 1.36E-08 4.29368 1.08E-06
F44E5.4 Hsp70 family 18.5558 2.86E-09 6.50486 4.08E-08
clec-2 C-type lectin 17.5573 1.56E-08 5.14494 4.39E-07
gst-16 glutathione S-transferase 16.8344 3.30E-09 8.24937 1.89E-08
F43E2.5 methionine sulfoxide-S-reductase
(MsrA)
16.6723 5.69E-09 5.49549 1.14E-07
hsp-16.1 heat shock protein HSP16-1 14.9708 1.10E-07 6.90193 8.15E-07
sdz-8 alcohol dehydrogenase 14.765 1.73E-10 6.55788 1.49E-09
ZK742.4 predicted NADH:flavin
oxidoreductase
14.2453 9.39E-09 7.42734 5.04E-08
H20E11.2 unknown 14.2209 6.13E-09 7.25052 3.53E-08
gst-5 glutathione S-transferase 12.8611 3.93E-10 6.47925 2.56E-09
C32H11.4 unknown 12.2617 1.28E-11 9.75833 2.26E-11
Y52E8A.3 unknown 11.9775 1.94E-09 10.165 2.92E-09
hsp-16.48 heat shock protein 11.9585 8.18E-09 7.00906 3.49E-08
F49F1.6 containing a signal sequence and
ShK toxin domains
10.8365 1.28E-08 4.10812 2.90E-07
cdr-4 glutathione S-transferase 10.6628 1.14E-08 4.46537 1.76E-07
Y40B10A.2 unknown 9.86761 5.76E-10 4.30897 8.49E-09
C55A6.6 alcohol dehydrogenase 9.78048 5.79E-08 5.28538 3.77E-07
ugt-13 ugt family 9.63811 1.88E-06 7.71078 3.47E-06
clec-143 C-type lectin 9.15882 1.75E-08 4.8121 1.36E-07
nit-1 Nitrilase 7.82259 7.22E-08 4.76861 3.72E-07
gst-4 glutathione S-transferase 7.60112 9.16E-09 5.85187 2.09E-08
C17H12.6 unknown 6.8668 1.65E-07 6.55322 1.91E-07
clec-9 C-type lectin 6.4249 1.88E-06 6.405 1.90E-06
dod-24 unknown 5.66907 6.82E-09 4.92816 1.13E-08
gst-7 glutathione S-transferase 4.92498 7.38E-08 4.22807 1.34E-07
C32H11.3 unknown 4.57737 3.54E-07 4.55978 3.60E-07
C12C8.2 cystathionine gamma-lyase
orthologous to human CTH
4.22098 2.29E-07 4.30506 2.11E-07
gst-20 glutathione S-transferase 4.16523 3.23E-07 4.9671 1.61E-07
F55G1.9 carboxylate reductase 4.09065 4.49E-09 4.61329 2.75E-09
doi:10.1371/journal.pone.0066431.t001
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Table 2. Oxidative stress and iron metabolism related gene expression is altered upon arsenic exposure in C. elegans.
Gene class Gene symbol P-value Fold change
Glutathione S-Transferase gst-1 7.05368E-08 3.67142
gst-2 1.23816E-06 16.4022
gst-3 0.000598368 2.02115
gst-4 9.15939E-09 7.60112
gst-5 3.92978E-10 12.8611
gst-6 6.35087E-08 3.62039
gst-7 7.37605E-08 4.92498
gst-8 0.000617048 2.08152
gst-9 1.05337E-06 10.5567
gst-10 1.08689E-05 1.58882
gst-12 2.51366E-08 32.4796
gst-13 2.19643E-08 7.52696
gst-14 3.17455E-06 5.83786
gst-16 3.30181E-09 16.8344
gst-19 4.29809E-08 28.44166
gst-20 3.22626E-07 4.16523
gst-22 2.83887E-05 1.85819
gst-23 0.00140456 21.38266
gst-25 2.85006E-09 29.8987
gst-26 1.01402E-08 27.46037
gst-27 6.8661E-11 23.00299
gst-28 4.10692E-06 23.23139
gst-29 0.00104296 21.92675
gst-30 2.74896E-10 64.4519
gst-31 6.48964E-07 9.26347
gst-36 0.00580448 1.21481
gst-38 2.6131E-10 44.4153
gst-39 1.262E-08 3.78938
gst-40 4.63406E-09 9.47291
gst-42 1.24648E-07 22.85235
gstk-1 0.000165975 21.60882
gsto-2 2.68578E-06 4.99268
gsto-3 1.13627E-07 5.62192
Superoxide dismutase sod-1 0.000634797 1.35592
sod-2 0.00234654 21.27465
sod-4 0.000138537 2.49845
Glutathione diSulfide Reductase C46F11.2 4.28943E-09 3.27018
Flavin-containing MonoOxygenase fmo-1 0.000092521 1.52425
fmo-2 9.40436E-07 3.03595
fmo-3 0.000199546 21.34887
fmo-5 5.92737E-05 21.60891
Glutamate Synthase W07E11.1 0.00131395 21.54529
Catalase ctl-1/ctl-3 1.96717E-06 2.33936
ctl-2 3.94594E-07 21.81633
Glutathione Peroxidase C11E4.1 9.01179E-05 22.21564
F26E4.12 0.000013568 2.04773
R05H10.5 9.17508E-06 4.41822
R03G5.5 4.31118E-05 21.34898
Heat Shock Protein hsp-1 5.78737E-05 1.52653
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to environmental heavy metal and metalloid exposure, the fraction
of the molecular mechanisms of pathogenesis induced by these
agents, that shared, is not known at the genomic level. We
compared C. elegans’ response to cadmium and arsenic using
previously published microarray dataset [38]. Using the same
threshold for both cadmium and arsenic response datasets (1.5 fold
p,0.0001), we found a significant overlap between affected genes
(Fig. 1A,B, Fig. S3, Table S3). We performed Gene Ontology
(GO) term enrichment analysis on cadmium microarray expres-
sion data. Some of the protein folding, and transport related GO
Table 2. Cont.
Gene class Gene symbol P-value Fold change
hsp-12.1 2.25089E-05 22.3433
hsp-12.2 0.00731473 21.24178
hsp-16.1/hsp-16.11 1.09759E-07 14.9708
hsp-16.2 6.75136E-08 31.7514
hsp-16.41 5.15451E-09 37.3042
hsp-16.48/hsp-16.49 8.17801E-09 11.9585
hsp-17 1.89686E-05 2.13635
hsp-25 0.0102672 21.22664
hsp-3 0.00126013 21.48891
hsp-4 0.000494313 1.39174
hsp-43 8.36411E-06 2.87926
hsp-6 7.8582E-07 4.9375
hsp-70 8.41166E-09 53.7595
F44E5.4 2.85528E-09 18.5558
Hedgehog-like Proteins grl-10 2.49496E-05 21.94499
grl-14 2.3101E-07 2.2902
grl-4 0.00135253 1.45752
grl-7 2.50635E-05 21.86634
wrt-6 21.33577 2.49E-03
wrt-1 21.38953 1.43E-04
grd-12 21.41453 1.18E-02
wrt-8 21.46887 8.54E-03
grd-11 21.4916 4.22E-03
grd-2 21.56007 1.09E-03
grd-5 21.58758 9.18E-06
qua-1 21.49428 6.25E-04
hog-1 21.61787 3.75E-05
wrt-3 21.84712 6.93E-04
wrt-4 21.95916 6.27E-07
wrt-2 22.25742 5.30E-05
grd-10 22.55 3.99E-05
grd-3 22.9124 1.51E-05
grd-1 23.13208 4.69E-05
wrt-10 24.24045 3.56E-08
Transcription Factor skn-1 0.000524389 2.10743
NADH Oxidase F56D5.3 4.55012E-07 42.8716
Mitochondrial Iron Transporter Sideroflexin sfxn-2 4.77799E-05 22.22696
sfxn-2 0.000478497 22.32737
sfxn-5 8.57816E-06 21.976
Ferritin ftn-1 2.59928E-08 55.3853
ftn-2 5.85469E-06 2.36642
Ferroportin fpn-1.1 7.19801E-09 6.49655
fpn-1.2 7.73361E-06 22.11996
doi:10.1371/journal.pone.0066431.t002
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term enrichments were present in cadmium response data (Fig.
S3A, B). Expression of zinc ion binding gene classes was depleted
in cadmium data, similar to our findings regarding arsenic,
paraquat stress, and hyperbaric oxygen stress data. GO class of
‘nematode larval development’ was found to be enriched in
cadmium response data but not in arsenic response data,
suggesting that different developmental consequences may arise
against arsenic and cadmium in C. elegans.
Robinson et al. reported arsenic- and cadmium-induced
toxicogenomic response in mouse embryos undergoing neurula-
tion. They examined the dose-dependent effects of arsenics and
cadmium on gene expression in association with increased
embryotoxicity in C57BL/6J mouse embryos, and identified
Figure 3. Genome-wide expression profile comparisons of C. elegans genes regulated by arsenic and oxidative stress. (A) A Venn
diagram illustrating number of genes expressed at high dose arsenic exposure, paraquat exposure, and overlap among these data. (B) A Venn
diagram illustrating number of genes expressed at high dose arsenic exposure, hyperbaric oxygen exposure, and overlap among these data. (C)
Enrichment of gene ontology categories for genes differentially expressed at paraquat exposure. (D) Enrichment of gene ontology categories for
genes differentially expressed at hyperbaric oxygen exposure.
doi:10.1371/journal.pone.0066431.g003
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overlapping and non-overlapping metal-induced gene expression
alterations [74]. They found that 1960 and 775 genes identified to
be significantly altered by arsenic and cadmium, respectively (F-
test, pb0.0001), and 116 of these genes overlapping between these
two populations. Understanding genomic level responses to
different heavy metals will help to resolve shared mechanisms of
heavy metal- induced diseases.
Genomic responses of C. elegans to environmental
contamination can be used as an ecotoxicogenomics
tool
Arsenic is ubiquitous throughout the earth crust in different
complex forms with pyrites [75], can easily dissociate from the
complex and enter into ground water [1], and be taken up by
microorganisms resulting in high levels of bio-availability [1,2].
Figure 4. Genome-wide expression profile comparisons of C. elegans genes regulated by arsenic and river sediment toxicants. (A) A
Venn diagram illustrating number of genes expressed at low and high dose arsenic exposure, Elbe River sediment exposure, and overlap among
these data. (B) A Venn diagram illustrating number of genes expressed at low and high dose arsenic exposure, Rhine River sediment exposure, and
overlap among these data. (C) Enrichment of gene ontology categories for genes differentially expressed at Elbe River sediment exposure. (D)
Enrichment of gene ontology categories for genes differentially expressed at Rhine River sediment exposure.
doi:10.1371/journal.pone.0066431.g004
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Because of these properties, arsenic is considered as an important
environmental toxin. Menzel et al. used C. elegans as a bio-monitor
to characterize sediment toxicity of German rivers Rhine and Elbe
[76]. In that study, C. elegans were exposed to sediments of three
German rivers, Danube, Rhine, Elbe; Danube being the cleanest,
and Elbe is the most contaminated among the three rivers, based
on chemical properties of the sediments, including arsenic levels.
Using expression profile of C. elegans exposed to Danube sediment
as a reference, they identified that 748 and 694 transcripts were
significantly altered in Elbe and Rhine exposed animals, respec-
tively. We wanted to address the question of how an expression
profile identified against a particular pollutant, in our case arsenic,
would correlate with an expression profile identified against
contaminated river sediments. We found bigger overlap between
global arsenic response and response to Elbe, which is the most
contaminated river in this study, with higher arsenic levels (Fig. 4,
Table S6, S7). These results indicate that C. elegans may be used as
an environmental bio-monitor, and meta- analysis of publicly
available C. elegans expression microarray data will provide a
platform to gain insights into complex environmental issues.
Discovering transcription factors of genomic response to
arsenic exposure in C. elegans using FastMEDUSA
We utilized FastMEDUSA to compute TFs involved in the
transcriptional response against high (0.03%) and low (0.003%)
concentrations of arsenic in C. elegans (see Materials and Methods).
We predicted ten consensus-significant TFs associated with high
concentration of arsenic (Table 3). As the transcriptional response
of C. elegans to low concentrations of arsenic was very minimal,
FastMEDUSA did not find any significant TFs associated with this
condition. We also predicted significant TF-gene associations
based on FastMEDUSA models and plotted them in a network
(Figure S4, Table S8).
Two of the predicted significant TFs, dnj-11and dac-1, were
tested for their contribution to arsenic stress response. We found
that loss of function of these genes using RNAi exhibited increased
lethality suggesting that these genes induce the stress response in C.
elegans (Fig. 5). dnj-11 encodes a protein containing DnaJ and Myb
domains that is orthologous to the mammalian ZRF1/MIDA1/
MPP11/DNAJC2 family of ribosome-associated molecular chap-
erones (Wormbase). MPP11 was identified as a leukemia-
associated antigen, and expression of this gene is up-regulated
during leukemic blasts in patients [77]. In rats, MPP11 homolog
MIDA1 was identified to induce humoral immune responses in
glioma, and immunization with MIDA1 containing plasmid
resulted in a significant suppression of tumor growth in immunized
animals [78,79].
Chromosomal defects involving MPP11 are associated with
primary head and neck squamous cell tumors [80]. Interestingly, a
recent study revealed that As2O3 had anti-cancer effects on both
cultured oral squamous cell carcinoma (OSCC) cells and OSCC
xenografts by inhibiting cell growth, suppressing angiogenesis and
Table 3. Transcription factors that are predicted to be involving in the response to arsenic exposure by FastMEDUSA.
Gene name Description Anatomic expression pattern
dac-1 Ortholog of SKI/SNO/DAC family of proteins nervous system, hypodermal seam cells
nhr-35 Nuclear hormone receptor Intestine
C32D5.1 Putative DNA binding domain Unknown
nhr-45 Nuclear hormone receptor Unknown
dnj-11 Ortholog of the mammalian ZRF1/MIDA1/MPP11/DNAJC2 family pharynx, intestine, muscle, nervous system,
reproductive system
mxl-2 Max-Like protein X - bHLH-Zip family protein hypodermis, intestine
R06C1.6 Uncharacterized protein Unknown
nhr-61 Nuclear hormone receptor Unknown
zip-4 Putative C/EBP protein, divergent ortologue to human CEBPA-Mutated in
acute myeloid leukemia
Weak general expression and higher
expression in pharynx and somatic gonad
ztf-22 Zinc finger putative Transcription Factor family Nervous system, head muscles, intestine
doi:10.1371/journal.pone.0066431.t003
Figure 5. Lethality assays of knock-downs of the FastMedusa
identified arsenic responsive regulatory genes. (Assays are
performed on arsenic exposure conditions.) (A) dnj-11(gk1025),
p,0.0001, (B) and dac-1(gk211), p,0.0001.
doi:10.1371/journal.pone.0066431.g005
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inducing apoptosis [81]. There is extensive evidence that arsenic
trioxide (As2O3), has a potential role of antitumor effect in vitro and
in vivo [24–26]. US Food and Drug Administration approved
As2O3 for the treatment of Acute Promyelocytic Leukemia (APL).
It’s well established that As2O3 can cure ,80–90% of newly
diagnosed APL patients [24–26]. Precise molecular mechanism of
the therapeutic effect of As2O3 is not known. Our results suggest a
molecular mechanism for the therapeutic effect of As2O3, such
that, As2O3 may regulate MPP11 expression, which may stimulate
immune responses lead to killing of leukemic blast cells, and
squamous cell carcinoma cells.
dac-1 encodes the C. elegans ortholog of Dachshund, a
transcriptional regulator of the SKI/SNO/DAC family of proteins
first described in Drosophila. The altered expression of DACH1, a
Drosophila Dachshund homolog, has been associated with tumor
progression and metastasis in human breast, prostate, ovarian and
endometrial cancers [82–86]. Another arsenic response gene
identified via FastMEDUSA is zip-4, a putative C/EBP protein,
divergent orthologue to human CEBPA gene, which is mutated in
acute myeloid leukemia [87]. We also identified several C. elegans
nuclear receptors (NRs) as arsenic responsive genes using Fast
MEDUSA. Nuclear receptors (NRs) encompass a family of
transcription factors often regulated by small lipophilic molecules,
such as steroids, retinoids, bile and fatty acids, that mediate
endocrine control [88]. C. elegans has a large family of NRs,
containing 284 of these receptors in its genome (wormbook). A
large percentage of human cancers, particularly breast, prostate,
and endometrial cancers, rely on steroid production for initial
growth [89,90]. Our data suggest that induction of NRs via arsenic
may contribute increased incidence of cancers in arsenic exposed
human populations.
Supporting Information
Figure S1 Boxplots which depict A) row data, and B)
data after normalization. PM only probe set signal was
applied.
(TIF)
Figure S2 qRT-PCR results for selected high ranker
genes.
(TIF)
Figure S3 GO term enrichments with cadmium in C.
elegans. (A) Enrichment of GO categories for 4-hour cadmium
exposure. (B) Enrichment of GO categories for 24-hour cadmium
exposure.
(TIF)
Figure S4 Significant transcription factor- gene inter-
actions in high arsenic condition. The color of the nodes
represent the overall expression of the gene (green: down-
regulated, red: up-regulated). The size of vertices is proportional
to their degree (i.e., number of edges incident on them). Each node
is labeled with the corresponding gene or TF’s name. Rounded
squares represent transcription factors, and circles represent
putative target genes of these transcription factors. The layout of
the network was generated manually on Cytoscape.
(TIF)
Table S1 List of primers used for qRT-PCR.
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Table S2 List of genes differentially expressed in both
high and low dose arsenic exposure (+/21.5 fold).
(DOCX)
Table S3 List of genes differentially expressed in both,
high dose arsenic, and cadmium 24-hour exposures (+/
21.5 fold).
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Table S4 List of genes differentially expressed in both,
high dose arsenic, and paraquat exposures (+/21.5
fold).
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Table S5 List of genes differentially expressed in both,
high dose arsenic, and hyperbaric oxygen exposures (+/
21.5 fold).
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Table S6 List of genes differentially expressed in both,
high dose arsenic exposure and Elbe River sediment
exposures (+/21.5 fold).
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Table S7 List of genes differentially expressed in both,
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exposures (+/21.5 fold).
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Table S8 Putative targets of top ten transcription
factors that are predicted to be involving in the response
to arsenic exposure by FastMEDUSA.
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